Envista Holdings jumps as Q2 results beat estimates, guidance raised

Published 31/07/2025, 21:44
Envista Holdings jumps as Q2 results beat estimates, guidance raised

Investing.com -- Envista Holdings Corporation (NYSE:NVST) shares surged 8.3% after the company reported second-quarter earnings that exceeded analyst expectations and raised its full-year outlook, driven by accelerated growth across all business segments and major geographies.

The dental products company reported adjusted earnings per share of $0.26 for the quarter ended June 27, 2025, beating analyst estimates of $0.23. Revenue came in at $682 million, significantly above the consensus estimate of $639.99 million, with core sales growth of 5.6% YoY.

"Envista achieved accelerated growth across all of our businesses and major geographies in the second quarter," said Paul Keel, CEO. "This allowed us to further increase investments in growth, operations, and people, while also delivering strong improvement in year-over-year profitability."

The company’s adjusted EBITDA rose 34% YoY to $84 million, with adjusted EBITDA margin expanding 240 basis points to 12.4%. Notably, all major businesses and geographies delivered positive growth, including Nobel Biocare in North America.

For the first half of 2025, Envista reported sales of $1.29 billion with core sales growth of 2.9% compared to the same period in 2024. First-half adjusted EPS reached $0.50, up 35% YoY.

Based on its strong performance, Envista raised its full-year 2025 guidance, now expecting core sales growth of 3% to 4%, up from the previous forecast of 1% to 3%. The company also increased its adjusted EPS outlook to $1.05-$1.15, above the analyst consensus of $1.02.

During the quarter, Envista repurchased 4.8 million shares for approximately $82 million, with $150 million remaining under its stock repurchase program at quarter-end.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.